Predicting Emergency Department Delirium With an Interactive Customizable Tablet to Prevent Repeat Visits (PrEDDICT-PReV)

April 8, 2019 updated by: Sunnybrook Health Sciences Centre

Predicting Emergency Department Delirium With an Interactive Customizable Tablet to Prevent Repeat Visits (PrEDDICT-PReV) App

Delirium is a common and serious complication of medical care that affects 10% of older Emergency Department (ED) patients, which unfortunately is unrecognized in up to 75% of ED patients.Studies have shown that 26 - 42% of patient with delirium are sent home. And 80% of patients sent home with unrecognized delirium are re-hospitalized within 4 days. Unrecognized delirium also has grave consequences for patient care - Kakuma showed that patient with unrecognized delirium who were sent home had 3-8x the mortality rate of patients with recognized delirium at 6 months.

Fluctuating severity over time is a key clinical characteristics of delirium, making its diagnosis challenging. Regardless of cause, failure to recognize delirium means that ED staff cannot meet their patient"s needs. For example, ED staff may miss serious medical conditions associated with delirium, may not provide understandable discharge instructions or ensure a caregiver can supervise and assist a patient with delirium who is discharged. These care adaptations require staff to recognize the presence of delirium. Thus it is not surprising that unrecognized delirium has such grave consequences for patients.

Thus recognition of delirium is critical to improving patient outcomes and reducing repeat ED visits. Patients with delirium may appear to have normal mental status at times, making its diagnosis challenging. High levels of service demand in the ED, plus the competing demands of numerous other initiatives to improve quality and reduce waiting times may explain why delirium continue to go unrecognized despite guidelines promoting routine delirium screening as a top priority in the ED. To address this care gap, the investigators developed an innovative solution. Rather than adding tasks to overburdened ED staff, our solution takes advantage of the long waiting times clients have in the ED for their initial assessments and between interactions with clinical staff. During these times, patients will use the PrEDICT "serious game" - similar to the Whack-a-Mole carnival game. The investigators have developed an algorithm based on participants" performance on this simple but serious game that can identify patients at high risk for delirium.

The investigators propose to conduct a prospective, multi-center randomized clinical trial in 4 provinces. The primary objective of this study is to assess the impact of our tablet technology on the recognition of delirium by ED staff. All eligible patients who agree to participate will be treated in the same manner and will play the PrEDICT tablet based game. The investigators will randomly assign half of patients to have their test performance shared with clinical staff. Patients assigned to the control condition will be treated using the current standard of care, clinical assessments, to identify delirium.

This project will allow us to solidly advance this technology from a working prototype (TRL7) to a commercially ready product demonstrated effective in multiple "real-world" environments under expected operational conditions (TRL8). Also it will provide evidence that the PrEDICT tablet app is clinically, technically, commercially and operationally feasible.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

1375

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Calgary, Canada
        • Recruiting
        • Alberta Health Services
        • Contact:
          • Hina Walia
    • Halifax
      • Nova Scotia, Halifax, Canada
        • Recruiting
        • Nova Scotia Health Authority
    • Ontario
      • Ottawa, Ontario, Canada, K1Y 4E9
        • Recruiting
        • Ottawa Hospital Research Institute
        • Contact:
          • Cathy Clement
      • Toronto, Ontario, Canada, M4N3M5
        • Recruiting
        • Sunnybrook Research Institute
        • Contact:
          • Joanna Yeung
    • Quebec
      • Québec, Quebec, Canada, G1J 1Z4
        • Recruiting
        • CHU de Québec - Université Laval
        • Contact:
          • Valérie Boucher

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 65 years of age and older
  • Have been in the ED for a minimum of 4 hours at the time of screening

Exclusion Criteria:

  • Live in a full care nursing home
  • Have a critical illness (Canadian Triage Acuity Score rendering them unable to communicate or provide consent)
  • Have delirium prior to ED arrival
  • Do not assent to study participation
  • Have visual impairment that makes them unable to use the serious game tablet
  • Have other communication difficulties preventing use of the serious game tablet

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Patients assigned to the control condition will be treated using the current standard of care, clinical assessments, to identify delirium.
Experimental: Intervention
PrEDICTgame score (subject's relative risk of delirium) will be shared with ED physicians in the intervention arm. After viewing the tests results, ED physicians will be asked to reassess delirium risk, and indicate if they would change their management based on the PrEDICT app scores.
PrEDICT game score will be shared with the emergency physicians and health care professionals

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delirium recognition by ED staff
Time Frame: Delirium recognition by ED staff will be measured during their index ED visit, within 4 hours of assessment using the PrEDICT app.
Design a simple dichotomous question to assess whether MD's clinically diagnose the presence of delirium in a specific patient(not delirious vs. delirious). In addition, ask MD's to rate their certainty of their diagnosis on a 10 point Numeric Rating scale. The primary outcome will be determined based on the dichotomous question
Delirium recognition by ED staff will be measured during their index ED visit, within 4 hours of assessment using the PrEDICT app.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ability of the PrEDICT app to identify patients with incident delirium
Time Frame: Between 7-14 days of ED discharge
Our Secondary outcome will be to correlate the PrEDICT game score with patients who develop incident delirium as assessed using the CAM
Between 7-14 days of ED discharge
Ability of the PrEDICT app to identify patients at high risk for incident delirium
Time Frame: Between 7-14 days of ED discharge
Our Secondary outcome will be to correlate the PrEDICT game score with patients who develop incident delirium as assessed using delirium index
Between 7-14 days of ED discharge
Unanticipated Barriers to using the PrEDICT app
Time Frame: Day 1(ED visit) to Day 4
Clinical feasibility will be assessed as the proportion of eligible patients that are able to complete use of the PrEDICT serious game.
Day 1(ED visit) to Day 4
Feasibility of Tablet Administration by Other Stakeholders
Time Frame: Day 1(ED visit) to Day 4
In patients who have already completed the main study and primary outcome, a convenience subsample will be recruited to compare the relative completion rate of the PrEDICT app by patients who are being supervised by: i) nurses; ii) trained hospital volunteers; and iii) family members and care givers.
Day 1(ED visit) to Day 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2018

Primary Completion (Anticipated)

January 1, 2020

Study Completion (Anticipated)

March 1, 2020

Study Registration Dates

First Submitted

December 20, 2017

First Submitted That Met QC Criteria

February 5, 2018

First Posted (Actual)

February 6, 2018

Study Record Updates

Last Update Posted (Actual)

April 10, 2019

Last Update Submitted That Met QC Criteria

April 8, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

Clinical Trials on PrEDICT game score

Subscribe